Pamela Marrone - Oct 31, 2022 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Pamela Marrone
Stock symbol
ATNF
Transactions as of
Oct 31, 2022
Transactions value $
$0
Form type
4
Date filed
11/2/2022, 05:02 PM
Previous filing
Jul 29, 2022
Next filing
May 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Award $0 +32K +113.88% $0.00 60.2K Oct 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in consideration for serving on the Board of Directors and as a Member of the Compensation and Risk, Safety and Regulatory Committees of the Board of Directors, for the quarter ended September 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.